{
  "docId": "019de073-187a-71e9-a3c0-2f4159454068",
  "docSlug": "48ce63a07f3c546c39a71c96ea43409e",
  "documentTitle": "AstraZeneca | Results Presentation Deck | 40 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 31,
  "pageCount": 40,
  "prevPage": 30,
  "nextPage": 32,
  "slideType": "appendix_data",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a matrix structure to map regulatory milestones against time periods.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-187a-71e9-a3c0-2f4159454068/31",
  "deckHref": "/decks/019de073-187a-71e9-a3c0-2f4159454068",
  "deckJsonHref": "/decks/019de073-187a-71e9-a3c0-2f4159454068.json",
  "deckAnchorHref": "/decks/019de073-187a-71e9-a3c0-2f4159454068#slide-31",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.95,
        "x": 0.03,
        "y": 0.92
      },
      "kind": "subtitle",
      "text": "1L = 1st-line; 2L = 2nd-line; 3L = 3rd-line; NSCLC = non-small cell lung cancer; gBRCAm = germline BRCA mutated; HER2+ = human epidermal growth factor receptor 2 positive; HER2-low = human epidermal growth factor receptor 2 low; CLL = chronic lymphocytic leukaemia; CKD = chronic kidney disease; NF1= neurofibromatosis type 1; PN = plexiform neurofibromas; HFpEF = heart failure with preserved ejection fraction; ATTrv-PN = hereditary transthyretin-mediated amyloid polyneuropathy; RSV = respiratory syncytial virus; NMOSD = neuromyelitis optica spectrum disorder; HR+ = hormone receptor-positive; HER2-neg = human epidermal growth factor receptor 2 negative; Dato-DxD = datopotamab deruxtecan; EOE = eosinophilic oesophagitis; EGFRm = epidermal growth factor receptor mutated; SCLC = small cell lung cancer; PNH = paroxysmal nocturnal haemoglobinuria; TNBC = triple negative breast cancer; MCL = mantle cell lymphoma; EGPA = eosinophilic granulomatosis with polyangiitis; HES = hyper eosinophilic syndrome.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ccc3e3fc-7147-4e60-b214-f5362e951f97",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.75,
        "w": 0.95,
        "x": 0.03,
        "y": 0.15
      },
      "kind": "table",
      "text": "Matrix of drug names, indications, and trial names organized by H2 2022, H1 2023, H2 2023 and Regulatory decision, Regulatory submission, Key Phase III data readouts.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "be335b40-0523-4ce7-a261-49b43121cc19",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Pipeline catalysts for 2022 - 2023",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8e6718a2-9be0-432a-bdaa-b6422dac12fa",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "matrix-nxn",
      "slug": null,
      "matchId": "1d5fedb0-856e-4714-8e6e-3e9376e43aa0",
      "evidence": "The slide organizes data into a grid of time periods vs. regulatory milestones.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}